Archives     Advertise     Editorial Calendar      Advertiser Index     Subscribe     Contact Us    


Concert Genetics Releases Comprehensive Genetic Test ID System


 

Concert Genetics has released its comprehensive genetic test identification system for use in the market, enabling a level of automation in test ordering, coverage, payment and clinical decision support that wasn't previously possible,

Concert's Genetic Testing Units (GTUs) are the first and only system that uniquely identifies all 160,000 genetic testing products, organizes them into a multi-level taxonomy, and incorporates new tests as they enter the market, which is currently happening at a rate of more than 30 per day. Initially developed as an internal test tracking system, Concert's GTUs have powered the company's widely used, end-to-end genetic test management solutions, becoming essential infrastructure for precision medicine in the process. Now they are available to the market at a time when the need for reliable test identification is critical for accuracy and reimbursement.

Ambiguity in test identification has created burdens for healthcare stakeholders. The company cited disagreements between health plans and laboratories about test reimbursement arising from the codes used to bill the test. Genetic tests are billed using an average of 6.9 codes per claim. in one study Concert found panel tests for hereditary cancer were billed with more than 2,100 different code combinations during a 36-month period. The inevitable confusion has led to a protracted series of denials and appeals that take away time and money.

"At Concert, we believe in the promise of precision medicine, and we recognize this promise will not become a reality until unnecessary friction is eliminated," said Rob Metcalf, CEO of Concert Genetics. "Today, every system of record in healthcare, from electronic medical records and lab information systems to billing and claims payment systems, operates with a different or incomplete language to identify tests. Without a common language, automated digital communication has been impossible, and manual work has been the only option. As of today, that is no longer the case."

Concert's GTU system assigns a five-digit alphanumeric code to each specific, orderable test from a specific lab. The system links to Concert's master test catalog and covers a wide range of clinical areas, including prenatal, pediatric, rare disease, pharmacogenomic, hereditary cancer, and somatic oncology tests. The system is organized into Concert's multi-level taxonomy, which groups the 160,000 individual testing products into almost 45,000 categories, which roll up into 34 domains and 8 clinical areas.

In the context of Concert's data platform, the test identification system also ties with other key data assets, including billing codes, lab quality information, and health plan medical coverage policies, enabling automation where manual work is otherwise required. This system builds on Concert's recently announced patent US10,896,405, for capabilities that support real-time, automated coverage determination and accurate reimbursement of genetic tests.

"The reason this system is transformative is that it eliminates manual work and potential for error at every step in the value chain," said Metcalf. "A test can be selected, authorized, ordered, resulted, billed, adjudicated, and correctly paid through a seamless exchange of information between systems that requires few if any manual stops, all because of unanimous agreement about the test in question."

From the homepage (ConcertGenetics.com), click on "Customer Login" and create a free account to access and view Concert GTUs, which are available on a royalty-free basis under the terms and conditions for many uses. Licenses for additional uses, including derivative works, can be obtained from Concert.

WEB:

Concert Genetics

Whitepaper on GTU System Design

 
Share:

Related Articles:


Recent Articles

AACR Establishes New Cancer Evolution Working Group

The American Association for Cancer Research (AACR) announced the formation of its seventh and newest scientific working group, which will be dedicated to supporting cancer evolution research.

Read More

Global Dementia Cases Forecasted To Triple By 2050

New analysis shows a decrease in prevalence due to education countered by increase due to heart health risk factors

Read More

Blackburn, Feinstein Introduce Bill to Protect Access to Breast Cancer Screenings

U.S. Senators Marsha Blackburn (R-Tenn.) and Dianne Feinstein (D-Calif.) today introduced the Protecting Access to Lifesaving Screenings (PALS) Act of 2021, a bill to preserve coverage for routine breast cancer screening for women beginning at age 40.

Read More

CUMBERLAND PHARMACEUTICALS REPORTS 2.5M PATIENT DOSES DELIVERED, NO PRODUCT RECALLS, NO FDA ISSUES IN 2020

The company's 2020 sustainability report highlights its commitment to environmental, social and governance (ESG) activities

Read More

Mobile Mentor Named Winner of Microsoft's 2021 Partner of the Year for Modern Endpoint Management

Mobile Mentor announced they have been awarded the 2021 Global Partner of the Year Award for Modern Endpoint Management.

Read More

Alzheimer's Association Welcomes CMS Announcement of National Coverage Determination Analysis on Treatment for Alzheimer's Disease

On behalf of all those living with Alzheimer's disease, their caregivers, and their families, we appreciate the Centers for Medicare & Medicaid Services (CMS) thoughtful consideration on coverage considerations for monoclonal antibodies targeting amyloid for the treatment of Alzheimer's disease, including aducanumab, which was recently approved by the Food and Drug Administration (FDA).

Read More

HCTec Acquires Talon Healthy IT Services

Healthcare IT firm adds industry-leading help desk service company to portfolio of solutions

Read More

The Seven Steps of Revenue Cycle for a Healthcare Practice

Revenue cycle management tracks patient revenue from the initial encounter with the healthcare system to payment of balance. Getting the seven steps of revenue cycle right helps providers avoid missteps that are costly to the bottom line.

Read More

Expanding Evidence-Based Care for Dementia

The Alzheimer's Association is on a mission to ensure care professionals have access to evidence-based training to ensure those with dementia receive quality care across all settings.

Read More

A Natural Leader

Nashville physician Dr. Ryan Mire to head nation's largest medical-specialty society.

Read More

Email Print
 
 

 

 


Tags:
Concert Genetics, Concert GTUs, Genetic Testing, Lab Reimbursement, Precision Medicine, Revenue Cycle Management
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: